[Expert consensus on the usefulness of natriuretic peptides in heart failure.]

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Kardiologia polska

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.5603/KP.2017.0020PMID 29399772
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

  2017cited by this paper
• Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care?

  2017influential reference
• Natriuretic Peptides and Analytical Barriers.

  2017cited by this paper
• 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

  2017cited by this paper
• Quality of care of hospitalised patients with heart failure in Poland in 2013: results of the second nationwide survey.

  2017cited by this paper
• The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.

  2016cited by this paper
• Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure: A Systematic Overview and Meta-Analysis.

  2016cited by this paper
• Predictors of one-year outcome in patients hospitalised for heart failure: results from the Polish part of the Heart Failure Pilot Survey of the European Society of Cardiology.

  2015cited by this paper
• Cost‐effectiveness of natriuretic peptide‐based screening and collaborative care: a report from the STOP‐HF (St Vincent's Screening TO Prevent Heart Failure) study

  2015cited by this paper
• BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review

  2014cited by this paper
• Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review

  2014cited by this paper
• Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.

  2014cited by this paper
• A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ÉLAN-HF Score

  2013cited by this paper
• PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial.

  2013cited by this paper
• Population of Polish patients participating in the Heart Failure Pilot Survey (ESC-HF Pilot).

  2013cited by this paper
• The costs of heart failure in Poland from the public payer's perspective. Polish programme assessing diagnostic procedures, treatment and costs in patients with heart failure in randomly selected outpatient clinics and hospitals at different levels of care: POLKARD.

  2013cited by this paper
• Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.

  2013cited by this paper
• Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care.

  2012influential reference
• Access to selected diagnostic procedures in the management of heart failure patients in Poland - POLKARD 2005.

  2010cited by this paper
• Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care.

  2009cited by this paper
• Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects.

  2009influential reference
• Biochemistry of B-type natriuretic peptide – where are we now?

  2008cited by this paper
• NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus.

  2008cited by this paper
• State of the art: Using natriuretic peptide levels in clinical practice

  2008influential reference
• Elevated BNP with normal systolic function in asymptomatic individuals at-risk for heart failure: a marker of diastolic dysfunction and clinical risk

  2006cited by this paper
• NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.

  2006influential reference
• Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.

  2005cited by this paper
• Impact of Obesity on Plasma Natriuretic Peptide Levels

  2004cited by this paper
• Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

  2004cited by this paper
• Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

  2002cited by this paper

• Hemodynamic, echocardiographic, and demographic profiles of patients with chronic thromboembolic pulmonary hypertension and atrial fibrillation: A multicenter cohort study.

  2025cites this paper
• Nurses as educators in the comprehensive heart failure care programme—Are we ready for it?

  2020cites this paper
• Feasibility of sacubitril/valsartan initiation early after acute decompensated heart failure.

  2020cites this paper
• Comprehensive Heart Failure Care pilot study: starting point and expected developments.

  2019cites this paper
• Sacubitril/valsartan and the risk of sudden cardiac death

  2018cites this paper
• Expert opinion of the Heart Failure Association of the Polish Cardiac Society, College of Family Physicians in Poland, and Polish Society of Family Medicine on the peri-discharge management of heart failure patients

  year unknowncites this paper